A carregar...
The mutational status of p53 can influence its recognition by human T-cells
p53 was reported to be an attractive immunotherapy target because it is mutated in approximately half of human cancers, resulting in its inactivation and often accumulation in tumor cells. Peptides derived from p53 are presented by class I MHC molecules and may act as tumor-associated epitopes which...
Na minha lista:
| Publicado no: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414872/ https://ncbi.nlm.nih.gov/pubmed/28507791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1285990 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|